154 related articles for article (PubMed ID: 12905507)
1. Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
Spencer K; Bindra R; Nix AB; Heath V; Nicolaides KH
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):142-8. PubMed ID: 12905507
[TBL] [Abstract][Full Text] [Related]
2. Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture.
Sahota DS; Leung TY; Chen M; Chan LW; Fung TY; Lau TK
Ultrasound Obstet Gynecol; 2010 Jul; 36(1):15-9. PubMed ID: 20503228
[TBL] [Abstract][Full Text] [Related]
3. Nuchal translucency thickness measurements for fetal aneuploidy screening: Log NT-MoM or Delta-NT, performer-specific medians and ultrasound training.
Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; Ombelet WU; Nijhuis JG
J Med Screen; 2006; 13(1):4-7. PubMed ID: 16569298
[TBL] [Abstract][Full Text] [Related]
4. A mixture model of nuchal translucency thickness in screening for chromosomal defects.
Wright D; Kagan KO; Molina FS; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Apr; 31(4):376-83. PubMed ID: 18383462
[TBL] [Abstract][Full Text] [Related]
5. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
6. Comparison between two methods of standardization for gestational age differences in fetal nuchal translucency measurement in first-trimester screening for trisomy 21.
Biagiotti R; Periti E; Brizzi L; Vanzi E; Cariati E
Ultrasound Obstet Gynecol; 1997 Apr; 9(4):248-52. PubMed ID: 9168573
[TBL] [Abstract][Full Text] [Related]
7. First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.
Chasen ST; Sharma G; Kalish RB; Chervenak FA
Ultrasound Obstet Gynecol; 2003 Aug; 22(2):149-51. PubMed ID: 12905508
[TBL] [Abstract][Full Text] [Related]
8. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
9. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
[TBL] [Abstract][Full Text] [Related]
10. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.
Zoppi MA; Ibba RM; Floris M; Monni G
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):649-51. PubMed ID: 11844208
[TBL] [Abstract][Full Text] [Related]
11. Preliminary normal reference values of nuchal translucency thickness in Taiwanese fetuses at 11-14 weeks of gestation.
Hsu JJ; Hsieh CC; Chiang CH; Lo LM; Hsieh TT
Chang Gung Med J; 2003 Jan; 26(1):12-9. PubMed ID: 12656304
[TBL] [Abstract][Full Text] [Related]
12. Prospective validation of first-trimester combined screening for trisomy 21.
Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
[TBL] [Abstract][Full Text] [Related]
13. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
[TBL] [Abstract][Full Text] [Related]
14. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
Lam YH; Tang MH; Lee CP; Tse HY
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
[TBL] [Abstract][Full Text] [Related]
15. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death.
Spencer K; Cowans NJ; Avgidou K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
[TBL] [Abstract][Full Text] [Related]
17. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
[TBL] [Abstract][Full Text] [Related]
18. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.
Gasiorek-Wiens A; Tercanli S; Kozlowski P; Kossakiewicz A; Minderer S; Meyberg H; Kamin G; Germer U; Bielicki M; Hackelöer BJ; Sarlay D; Kuhn P; Klapp J; Bahlmann F; Pruggmayer M; Schneider KT; Seefried W; Fritzer E; von Kaisenberg CS;
Ultrasound Obstet Gynecol; 2001 Dec; 18(6):645-8. PubMed ID: 11844207
[TBL] [Abstract][Full Text] [Related]
19. The distribution of nuchal translucency at 10-13 weeks of pregnancy.
Schuchter K; Wald N; Hackshaw AK; Hafner E; Liebhart E
Prenat Diagn; 1998 Mar; 18(3):281-6. PubMed ID: 9556045
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy.
Brizot ML; Snijders RJ; Bersinger NA; Kuhn P; Nicolaides KH
Obstet Gynecol; 1994 Dec; 84(6):918-22. PubMed ID: 7526305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
